ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,906, issued on Sept. 1, was assigned to The Brigham and Women's Hospital Inc. (Boston). "Kidney targeted delivery of drugs" was invented by... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,907, issued on Sept. 1, was assigned to Oregon State University (Corvallis, Ore.) and Oregon Health & Science University (Portland, Ore.). ... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,908, issued on Sept. 1, was assigned to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,909, issued on Sept. 1, was assigned to The University of British Columbia (Vancouver, Canada). "Compositions and systems comprising transf... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,910, issued on Sept. 1, was assigned to Imam Abdulrahman Bin Faisal University (Dammam, Saudi Arabia). "Method for treating cancerous tissu... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,911, issued on Sept. 1, was assigned to Imam Abdulrahman Bin Faisal University (Dammam, Saudi Arabia). "Methods for preparing nanotherapeut... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,912, issued on Sept. 1, was assigned to Curium US LLC (St. Louis). "Radiopharmaceutical compositions for actinium in targeted radionuclide ... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,913, issued on Sept. 1, was assigned to Actinium Pharmaceuticals Inc. (New York). "DR5 radioimmunotherapy in the treatment of solid cancers... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,914, issued on Sept. 1, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Radiolabeled anti-LAG3 antibodies for immuno-PET... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,915, issued on Sept. 1, was assigned to ACTINIUM PHARMACEUTICALS INC. (New York). "HER3 radioimmunotherapy for the treatment of solid cance... Read More